These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Effect of Nin-formylation of the tryptophan residue on gastrin (HG-13) binding and on gastric acid secretion. Magous R; Bali JP; Moroder L; Previero A Eur J Pharmacol; 1982 Jan; 77(1):11-6. PubMed ID: 6277651 [TBL] [Abstract][Full Text] [Related]
49. Cyclic cholecystokinin analogues with high selectivity for central receptors. Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318 [TBL] [Abstract][Full Text] [Related]
50. Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics. Goudreau N; Weng JH; Roques BP Arch Pharm (Weinheim); 1996 Apr; 329(4):197-204. PubMed ID: 8669984 [TBL] [Abstract][Full Text] [Related]
51. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Lotti VJ; Chang RS Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567 [TBL] [Abstract][Full Text] [Related]
52. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions. Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777 [TBL] [Abstract][Full Text] [Related]
53. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718. Roche S; Bali JP; Galleyrand JC; Magous R Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638 [TBL] [Abstract][Full Text] [Related]
54. Properties of receptors for gastrin and CCK on gastric smooth muscle cells. Menozzi D; Gardner JD; Jensen RT; Maton PN Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654 [TBL] [Abstract][Full Text] [Related]
55. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482 [TBL] [Abstract][Full Text] [Related]
57. Conformational calculations on gastrin C-terminal tetrapeptide. Abillon E; Van Chuong PP; Fromageot P Int J Pept Protein Res; 1981 Apr; 17(4):480-5. PubMed ID: 7309351 [TBL] [Abstract][Full Text] [Related]
58. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371 [TBL] [Abstract][Full Text] [Related]
59. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors. Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338 [TBL] [Abstract][Full Text] [Related]
60. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]